Overview A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors Status: Not yet recruiting Trial end date: 2025-03-20 Target enrollment: Participant gender: Summary Study will be conducted with 2 stages. Phase: Phase 1/Phase 2 Details Lead Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.